Rabbit Recombinant Monoclonal CAMKIV antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 4 publications.
View Alternative Names
CAMK, CAMK-GR, CAMKIV, CAMK4, Calcium/calmodulin-dependent protein kinase type IV, CaMK IV, CaM kinase-GR
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-CAMKIV antibody [EP2565AY] (AB68218)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized HeLa (human cervical adenocarcinoma epithelial cell) cells labelling CAMKIV with ab68218 at 1/50 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed (ab150081) at 1/1000 dilution at RT for 45 min. Alexa Fluor® 594 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (ab195889) at 1/200 dilution, was co-incubated with ab68218 overnight at 4° C. Nucleus were visualized using DAPI.
- WB
Lab
Western blot - Anti-CAMKIV antibody [EP2565AY] (AB68218)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Exposure time : Lane 1, 5 seconds; Lane 2, 20 seconds.
All lanes:
Western blot - Anti-CAMKIV antibody [EP2565AY] (ab68218) at 1/10000 dilution
Lane 1:
Jurkat (Human T cell leukemia T lymphocyte) whole cell lysate at 15 µg
Lane 2:
Human brain lysate at 15 µg
Secondary
Lane 1:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Lane 2:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 52 kDa
Observed band size: 52 kDa
false
Related conjugates and formulations (2)
-
Anti-CAMKIV antibody [EP2565AY] - BSA and Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-CAMKIV antibody [EP2565AY]
Reactivity data
Product details
This product has switched from a hybridoma to recombinant production method on 29th August 2024.
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CaMKIV takes part in the regulation of gene expression and is involved in neural signaling cell cycle control and immune responses. This kinase forms part of a larger signaling complex that facilitates specific cellular events. Its activity affects processes such as long-term potentiation and T-cell maturation indicating its significance in both the nervous and immune systems.
Pathways
CaMKIV integrates into several signaling pathways including the calcium signaling pathway and CREB (cAMP response element-binding protein) pathway. Through these pathways CaMKIV activates CREB via phosphorylation linking it to gene transcription processes essential for memory formation. CaMKIV acts alongside proteins like other CaM kinases such as CaMKI and CaMKII to ensure efficient signal transduction.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Journal of neuroinflammation 21:276 PubMed39465429
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:4255 PubMed35869084
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of biomedical materials research. Part B, Applied biomaterials 110:1594-1603 PubMed35106922
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular neurobiology 57:1622-1635 PubMed31808063
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com